PMEF
NVAX icon

Point72 Middle East FZE’s Novavax NVAX Stock Holding History

Point72 Middle East FZE’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-222,600
Closed -$1.65M – 1741
2023
Q2 		$1.65M Buy
+222,600
New +$1.75M 0.05% 430
2023
Q1 		– Sell
-30,331
Closed -$312K – 2036
2022
Q4 		$312K Buy
+30,331
New +$535K 0.01% 887

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Middle East FZE's NVAX Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Novavax (NVAX) in Q3 2023, closing a stake of 222,600 shares — an estimated $1.65M sold.

Point72 Middle East FZE first reported a position in NVAX in Q4 2022 and held it in 2 quarters. The position peaked at $1.65M in Q2 2023. 225 funds tracked by Wall St. Rank hold NVAX as of Q3 2023.

  • Point72 Middle East FZE reported no remaining Novavax position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 222,600 Novavax shares in Q3 2023, an estimated $1.65M.
  • Point72 Middle East FZE first reported a position in Novavax in Q4 2022 and held it in 2 quarters.
  • Point72 Middle East FZE's Novavax position peaked at $1.65M in Q2 2023.
  • 225 funds tracked by Wall St. Rank held Novavax as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.